You are here:
Name SMC ID No Manufacturer Status Sub. Type
 
aflibercept (Eylea) 857/13 Bayer plc/Bayer Schering Pharma Accepted Full submission
aflibercept (Eylea) 1186/16 Bayer plc/Bayer Schering Pharma Accepted Full submission
aflibercept (Eylea) 1003/14 Bayer plc/Bayer Schering Pharma Restricted Full submission
aflibercept (Eylea) 1074/15 Bayer plc/Bayer Schering Pharma Accepted Full submission
aflibercept intravitreal (Eylea®) 954/14 Bayer plc/Bayer Schering Pharma Accepted Full submission
azithromycin dihydrate (Azyter) 804/12 Not Recommended Non submission
Bimatoprost (Lumigan®) 07/02 Allergan Ltd Accepted Full submission
bimatoprost + timolol (Ganfort Unit Dose Preservative Free) 906/13 Allergan Ltd Restricted Abbreviated Submission
bimatoprost 0.3mg/mL single-dose eye drops (Lumigan UD) 839/13 Allergan Ltd Restricted Abbreviated Submission
bimatoprost timolol Ganfort 312/06 Allergan Ltd Accepted Abbreviated Submission
Brimonidine/timolol (Combigan®) eye drops 196/05 Allergan Ltd Accepted Abbreviated Submission
brinzolamide and brimonidine (Simbrinza) 991/14 Alcon Eye Care UK Ltd Accepted Abbreviated Submission
brinzolomide 10mg/ml eye drops, suspension (Azopt) 546/09 Alcon Laboratories UK Ltd Accepted Abbreviated Submission
brinzolomide/timolol eye drops (Azarga) 568/09 Alcon Laboratories UK Ltd Accepted Abbreviated Submission
bromfenac (Yellox) 740/11 Bausch and Lomb GmbH Not Recommended Non submission
Carbomer 0.25% gel (Liquivisc®) 191/05 Allergan Ltd Accepted Abbreviated Submission
cefuroxime (Aprokam) 932/13 Thea Pharmaceuticals Accepted Abbreviated Submission
ciclosporin (Ikervis) 1089/15 Santen Accepted Full submission
dexamethasone (Ozurdex) 652/10 Allergan Ltd Not Recommended Full submission
dexamethasone (Ozurdex) 652/10 Allergan Ltd Not Recommended Resubmission
dexamethasone (Ozurdex) 652/10 Allergan Ltd Restricted Resubmission
dexamethasone (Ozurdex) 1046/15 Allergan Ltd Accepted Full submission
dexamethasone (Ozurdex) 751/11 Allergan Ltd Superseded Non submission
dorzolamide (Trusopt) 238/06 MSD Restricted Abbreviated Submission
dorzolomide (Cosopt) 293/06 MSD Restricted Abbreviated Submission
epinastine (Relestal) 267/06 Allergan Ltd Not Recommended Non submission
fluocinolone acetonide (Iluvien) 864/13 Alimera Sciences Restricted Resubmission
idebenone (Raxone) 1226/17 Santhera Pharmaceuticals Restricted Full submission
Ketotifen hydrogen fumarate (Zaditen®) 65/03 Novartis Pharmaceuticals UK Ltd Not Recommended Non submission
latanoprost (Monopost) 879/13 Spectrum Thea Pharmaceuticals Limited Restricted Abbreviated Submission
Latanoprost (Xalatan) 102/04 Pfizer Ltd Restricted Full submission
latanoprost timolol maleate (Xalacom) 432/07 Pfizer Ltd Accepted Abbreviated Submission
loteprednol etabonate 0.5% 5mg/ml (Lotemax 0.5% eye drops suspension) 484/08 Bausch and Lomb GmbH Not Recommended Non submission
nepafenac (Nevanac) 588/09 Alcon Laboratories UK Ltd Not Recommended Non submission
nepafenac (Nevanac) 813/12 Alcon Laboratories UK Ltd Accepted Full submission
nepafenac (Nevenac) 1228/17 Alcon Laboratories UK Ltd Accepted Abbreviated Submission
ocriplasmin (Jetrea) 892/13 Thrombogenics NV Not Recommended Full submission
ocriplasmin (Jetrea) 892/13 Thrombogenics NV Restricted Resubmission
Olopatadine 1mg/ml eye drops, solution (Opatanol®) 59/03 Alcon Laboratories UK Ltd Accepted Resubmission
Olopatadine 1mg/ml eye drops, solution (Opatanol®) 59/03 Alcon Laboratories UK Ltd Not Recommended Full submission
Pegaptanib (Macugen) 290/06 Pfizer Ltd Superseded Full submission
ranibizumab (Lucentis) 711/11 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
ranibizumab (Lucentis) 711/11 Novartis Pharmaceuticals UK Ltd Restricted Resubmission
ranibizumab (Lucentis) 732/11 Novartis Pharmaceuticals UK Ltd Restricted Full submission
ranibizumab (Lucentis) 732/11 Novartis Pharmaceuticals UK Ltd Accepted Resubmission
ranibizumab (Lucentis) 907/13 Novartis Pharmaceuticals UK Ltd Accepted Full submission
ranibizumab 10mg/ml solution for intravitreal injection (Lucentis) 381/07 Novartis Pharmaceuticals UK Ltd Superseded Full submission
tafluprost (Saflutan) 581/09 MSD Restricted Full submission
tafluprost + timolol (Taptiqom) 1085/15 Santen Restricted Abbreviated Submission
timolol eye gel (Tiopex) 941/14 Restricted Abbreviated Submission
travoprost (Travatan) 1091/15 Alcon Laboratories UK Ltd Accepted Abbreviated Submission
Travoprost (Travatan®) 60/04 Alcon Laboratories UK Ltd Restricted Full submission
Travoprost/timolol (Duotrav®) 294/06 Alcon Laboratories UK Ltd Accepted Abbreviated Submission

Back